Oxiconazole Potentiates Gentamicin against Gentamicin-Resistant Staphylococcus aureus <i>In Vitro</i> and <i>In Vivo</i>-Reference-Cited by-同舟云学术

Oxiconazole Potentiates Gentamicin against Gentamicin-Resistant Staphylococcus aureus In Vitro and In Vivo

Published:2023-08-17 Issue:4 Volume:11 Page:
ISSN:2165-0497
Container-title:Microbiology Spectrum
language:en
Short-container-title:Microbiol Spectr

Author:

Kaul Grace¹²,Akhir Abdul¹,Shukla Manjulika¹,Shafi Hasham³,Akunuri Ravikumar⁴,Pawar Gaurav⁴,Ghouse Mahammad⁴,Srinivas Nanduri⁴,Chopra Sidharth¹²^ORCID

Affiliation:

1. Division of Molecular Microbiology and Immunology, Lucknow, Uttar Pradesh, India

2. Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, India

3. Division of Pharmaceutics & Pharmacokinetics, CSIR-Central Drug Research Institute, Lucknow, Uttar Pradesh, India

4. Department of Chemical Sciences, NIPER Hyderabad, Hyderabad, Telengana, India

Abstract

Staphylococcus aureus , which causes the majority of nosocomial and community-acquired infections globally, is a WHO high-priority pathogen for antibiotic research and development. In addition to invasive infections, it is the causative agent of moderate to severe skin infections, with an increasing prevalence of infections caused by MDR strains such as methicillin-resistant S. aureus (MRSA).

Funder

Department of Biotechnology, Ministry of Science and Technology, India

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Cell Biology,Microbiology (medical),Genetics,General Immunology and Microbiology,Ecology,Physiology

Link

https://journals.asm.org/doi/pdf/10.1128/spectrum.05031-22

Reference44 articles.

1. WHO. 2017. WHO publishes list of bacteria for which new antibiotics are urgently needed. https://www.who.int/publications/i/item/WHO-EMP-IAU-2017.12. Accessed 21 October 2022.

2. The post-antibiotic era is here

3. O’Neill J. 2016. Tackling drug-resistant infections globally: final report and recommendations. https://amr-review.org/sites/default/files/160518_Final%20paper_with%20cover.pdf. Accessed 21 October 2022.

4. WHO. 2020. Lack of new antibiotics threatens global efforts to contain drug-resistant infections https://www.who.int/news/item/17-01-2020-lack-of-new-antibiotics-threatens-global-efforts-to-contain-drug-resistant-infections. Accessed 21 October 2022.

5. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Naturally Derived Malabaricone B as a Promising Bactericidal Candidate Targeting Multidrug-Resistant Staphylococcus aureus also Possess Synergistic Interactions with Clinical Antibiotics;Antibiotics;2023-09-26